Indications and Contraindications

To be treated with Transcutaneous Vagus Nerve Stimulation (tNVS)

● Tinnitus (see 30 studies)

● Sleep disorders (see study no. 25)

● Anxiety disorders

● Depression (FDA approved)

Chronic fatigue / burnout

● Long-covid syndrome (see study no. 27)

● Fibromyalgia

● Intestinal complaints / digestive disorders

● Headache

● Migraine (FDA approved)

● Epilepsy (FDA approved - consult your doctor first)

● Concentration problems

● Memory disorder (see studies 5, 10, 16 & 19)

● Pain in the neck and shoulders (stress, see study 11)

● Tachycardia (high heart rate)

● Subacute chronic inflammatory conditions (e.g. leaky gut wall)

● Heartburn (reflux)

● Diabetes (see study no. 21)

● Parkinson's (see study no. 22)

● Rehabilitation after stroke (see, among others, research no. 9, 18, 22, 23)

CONTRAINDICATIONS:

Transcutaneous vagus nerve stimulation is generally considered safe, but has several contraindications. It should not be used during pregnancy or if you have a pacemaker or other implanted medical device. Furthermore, tVNS is not recommended if you have an active infection or open wounds near the stimulation site, or if you have a cerebral shunt. Consult your doctor if necessary. Consult your doctor if you have epilepsy.

Transcutaneous vagus nerve stimulation reduces tinnitus symptoms in 40% of patients, with a sustained effect after three months.

- 36% improvement in 'well-being' according to the WHO wellbeing questionnaire

- 43% improvement in quality of life, as measured by the tinnitus handicap score

Brain scans show that transcutaneous vagus nerve stimulation reduces the sensitivity of the auditory system. This suggests that:

1. Normalization of the overactive auditory cortex suppresses tinnitus

2. The limbic system, related to the onset and worsening of tinnitus, is suppressed

An individual treatment approach will be discussed during the first visit.

Click here for a more detailed explanation supported by 30 studies.